Lilly Articles
Japan stock market week to Feb 19, 2007
26 February 2007
Lilly granted injunction on document leaks
26 February 2007
Japan stock market week to Feb 12, 2007
19 February 2007
Lilly completes $2.3B ICOS purchase
12 February 2007
Lilly's income down 81%, but shares up 1.5%
12 February 2007
Amylin/Lilly's Byetta comparable to insulin
7 February 2007
EC clears Roche's Tarceva in pancreatic cancer
5 February 2007
ICOS shareholders vote "yes" to Lilly merger
5 February 2007
Japan stock market week to Jan 22, 2007
29 January 2007
Cylene closes $44M financing
29 January 2007
Ph III prasugrel trial completes enrollment
29 January 2007
Lilly halts Va insulin plant construction
22 January 2007
Lilly licenses PSN010 from OSI subsid
15 January 2007
Roche/Genentech
15 January 2007
Eli Lilly settles further Zyprexa law suits
15 January 2007
Good patent news for Lilly, Pfizer and Sanofi-Aventis
8 January 2007
Byetta gets FDA OK for use with TZD
8 January 2007
US breast cancer fall: better drugs or less HRT?
8 January 2007
UPDATE: Lilly increases ICOS offer 6% to $2.3B
22 December 2006
Lilly accused of off-label Zyprexa promotion
22 December 2006
Lilly increases ICOS offer 6% to $2.3B
22 December 2006
"Brain drain" reversal boosts India's drug R&D
22 December 2006
Japan stock market week to Dec 11, 2006
18 December 2006
Lilly reiterates 2006/07 guidance, disappoints
18 December 2006
Lilly pledges $10M to IDF BRIDGES program
18 December 2006
Eli Lilly submits Evista NDA to FDA
18 December 2006
Affimed's antithrombotic Ab completes proof-of-concept trial
11 December 2006
Promising metastasis data for SR's Atu027 RNAi
11 December 2006
Lilly maintains cost-effectiveness of Zyprexa
11 December 2006
Lilly/Amylin's Byetta cleared in Europe
27 November 2006
Headlines 25 years ago this week....
27 November 2006
Japan's generic drugs market expected to grow 8.8% from 2006 to 2008
27 November 2006
Daiichi Sankyo discusses R&D pipeline
27 November 2006
Eli Lilly will not cut back in France
20 November 2006
Japan stock market week to Oct 30, 2006
6 November 2006
SCP to distribute Dong-A's Zydena in Middle East
6 November 2006
Poland's drug market up 4% in first 7 months
6 November 2006
Strattera helps patients with reading disorders
6 November 2006
Stock Commentary - New York week to Oct 23, 2006
30 October 2006
Lilly's Almita enters Ph III trial for SCLC
30 October 2006
Lilly invests $560M in biotech expansion
30 October 2006
Amylin's losses down 37% in 3rd-qtr
30 October 2006
Lilly's 3rd-qtr 2006 profit rises 10% on Zyprexa
30 October 2006
Lilly to buy ICOS for $2.1B, $32 per share
23 October 2006
Headlines 25 years ago this week....
16 October 2006
US counterfeit drug scam used Internet spam
9 October 2006
Eli Lilly PAP approved, patients hit by Part D loophole
9 October 2006
CHMP positive about exenatide in diabetes
2 October 2006
EASD panels recommend insulin acceptance, and highlight shortfalls in DPNP therapy
25 September 2006
Doctors complain of poor training in depression diagnosis
25 September 2006
Varying impact of US Medicare Part D on top 10 durgmakers
11 September 2006
Eli Lilly chief says eliminating barriers is crucial to increasing competitiveness
11 September 2006
Eli Lilly's Arxxant gets FDA approvable letter
28 August 2006
Light therapy better than Prozac in SAD
14 August 2006
Amylin's 2nd-qtr loss deepens to $46.4M
31 July 2006
Lilly swings to 2nd-qtr 2006 EPS of $0.76
31 July 2006
Japan stock market week to July 24, 2006
26 July 2006
Lilly's Gemzar wins 4th US cancer indication
24 July 2006
FDA open to adaptive clinical trials
24 July 2006
Merieux succession on the agenda
24 July 2006
UK plant closure warning by ABPI
17 July 2006
InPharmatica licenses AI to Eli Lilly & Co
10 July 2006
NICE says "no" to Lilly's Alimta
10 July 2006
Headlines 25 years ago this week....
3 July 2006
Stock Commentary - New York week toJune 26, 2006
3 July 2006
Eli Lilly to close three European facilities
3 July 2006
Strong Ph III data for Lilly's DR drug
19 June 2006
Good 2 yr sugar control on Amylin/Lilly's Byetta
19 June 2006
Weight loss in diabetics lowers health costs
13 June 2006
Lilly's Alimta 'as effective as Taxotere'
12 June 2006
EU filing for once-daily dosing of Cialis
12 June 2006
Lilly's enzastaurin: good combo drug at Ph I
12 June 2006
Strong Ph II biomarker data for Lilly's Alimta
12 June 2006
Lilly's enzastaurin enters Ph III NHL trials
5 June 2006
Development of B-MS' Pargluva discontinued
29 May 2006
Cymbalta: less impact on sex than Lexapro
29 May 2006
US patient assistance programs under review
29 May 2006
Cabrellis Pharma makes its debut
29 May 2006
Global diabetes drug market worth $15B in 2005
22 May 2006
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
